PlainRecalls
FDA Drug Moderate Class II Ongoing

Valsartan and Hydrochlorothiazide Tablets, Valsartan 160 MG and Hydrochlorothiazide 12.5 MG, 90 tablets per bottle, Rx Only, MFG: Arrow Pharm (Malta) LTD, Birzebbugia, BBG 3000 Malta. NDC: 54569-6480-0

Reported: August 29, 2018 Initiated: July 17, 2018 #D-1110-2018

Product Description

Valsartan and Hydrochlorothiazide Tablets, Valsartan 160 MG and Hydrochlorothiazide 12.5 MG, 90 tablets per bottle, Rx Only, MFG: Arrow Pharm (Malta) LTD, Birzebbugia, BBG 3000 Malta. NDC: 54569-6480-0

Reason for Recall

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Details

Units Affected
524 bottles
Distribution
Nationwide USA
Location
Libertyville, IL

Frequently Asked Questions

What product was recalled?
Valsartan and Hydrochlorothiazide Tablets, Valsartan 160 MG and Hydrochlorothiazide 12.5 MG, 90 tablets per bottle, Rx Only, MFG: Arrow Pharm (Malta) LTD, Birzebbugia, BBG 3000 Malta. NDC: 54569-6480-0. Recalled by A-S Medication Solutions LLC.. Units affected: 524 bottles.
Why was this product recalled?
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 29, 2018. Severity: Moderate. Recall number: D-1110-2018.